相关实验视频
Updated: Feb 13, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
沈陵百祖配方中的多糖结构差异及其在性结肠炎和易怒肠综合征中的治疗作用
Chen Li1, Ning An2, Jingyue Zhang3
1Key Laboratory of Xinjiang Phytomedicine resource and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi, 832000, Xinjiang, China; School of Pharmacy, Lanzhou University, Lanzhou, 730000, Gansu, China.
不同的沈陵百祖 (SLBZ) 配方表现出不同的治疗潜力. 粉末和药丸形式的多糖类与颗粒相比,具有优越的抗炎和抗氧化作用,与结构差异有关.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 沈陵百祖 (SLBZ) 配方是一种治疗消化障碍的中国传统药物.
- 现代的SLBZ配方旨在提高患者的遵守性.
- 对于SLBZ配方之间的疗效差异还没有很好地理解.
研究的目的:
- 评估SLBZ配方之间潜在的治疗疗效差异.
- 专注于多糖类作为关键的生物活性成分.
- 为了研究SLBZ多糖的结构-活性关系.
主要方法:
- 从SLBZ粉末,药片和颗粒配方中提取和结构性表征多糖.
- 提取的多糖的抗炎和抗氧化作用的评估.
- 在动物模型中对性结肠炎 (UC) 和伴有腹的刺激性肠综合征 (IBS-D) 的治疗效果的评估.
主要成果:
- 来自SLBZ粉末和药丸配方的多糖体表现出比颗粒中的多糖体更强的抗炎和抗氧化活性.
- 粉末和药丸衍生的多糖类具有更高的尿酸水平,更复杂的单糖类概况和更大的分子量.
- 这些结构特征可能与UC和IBS-D模型中的增强治疗疗效相关.
结论:
- SLBZ配方表现出不同的多糖体配置和生物活性.
- 由于SLBZ的粉末和药丸配方,由于其多糖化合物的组成,SLBZ可能为消化障碍提供更好的治疗益处.
- 研究结果提供了关于SLBZ多糖的结构-活性关系的见解,以优化传统中医药的疗效.
更多相关视频
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Ulcerative Colitis in IBD
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...